Found: 59
Select item for more details and to access through your institution.
Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1163768
- By:
- Publication type:
- Article
Refining patient selection for next-generation immunotherapeutic early-phase clinical trials with a novel and externally validated prognostic nomogram.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1323151
- By:
- Publication type:
- Article
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancer.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 602, p. 1, doi. 10.1126/scitranslmed.aba4627
- By:
- Publication type:
- Article
Exploration of Novel Prognostic Markers in Grade 3 Neuroendocrine Neoplasia.
- Published in:
- Cancers, 2021, v. 13, n. 16, p. 4232, doi. 10.3390/cancers13164232
- By:
- Publication type:
- Article
Phenotypic Characteristics of the Tumour Microenvironment in Primary and Secondary Hepatocellular Carcinoma.
- Published in:
- Cancers, 2021, v. 13, n. 9, p. 2137, doi. 10.3390/cancers13092137
- By:
- Publication type:
- Article
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1862, doi. 10.3390/cancers12071862
- By:
- Publication type:
- Article
Presenting Features and Early Mortality from SARS-CoV-2 Infection in Cancer Patients during the Initial Stage of the COVID-19 Pandemic in Europe.
- Published in:
- Cancers, 2020, v. 12, n. 7, p. 1841, doi. 10.3390/cancers12071841
- By:
- Publication type:
- Article
Interleukin-6 Polymorphisms and Gender: Relationship with the Occurrence of Hepatocellular Carcinoma in Patients with End-Stage Liver Disease.
- Published in:
- Oncology, 2009, v. 77, n. 5, p. 304, doi. 10.1159/000260057
- By:
- Publication type:
- Article
Immunotherapy in Hepatocellular Carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Impact of performance status on treatment outcomes: A real-world study of advanced urothelial cancer treated with immune checkpoint inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Cancer-related inflammation: An emerging prognostic domain in metastatic castration-resistant prostate carcinoma.
- Published in:
- 2014
- By:
- Publication type:
- Editorial
Developing an objective marker to optimize patient selection and predict survival benefit in early-phase cancer trials.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 2, p. 262, doi. 10.1002/cncr.28381
- By:
- Publication type:
- Article
New Frontiers in the Medical Therapy of Hepatocellular Carcinoma.
- Published in:
- Chemotherapy (0009-3157), 2022, v. 67, n. 3, p. 164, doi. 10.1159/000521837
- By:
- Publication type:
- Article
Preliminary qualification of a novel, hypoxic-based radiologic signature for trans-arterial chemoembolization in hepatocellular carcinoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Acceleration of interstitial lung disease induced by raltitrexed.
- Published in:
- Journal of Oncology Pharmacy Practice, 2020, v. 26, n. 5, p. 1241, doi. 10.1177/1078155219887213
- By:
- Publication type:
- Article
Correction to: Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Correction: Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
- Published in:
- European Radiology, 2024, v. 34, n. 1, p. 724, doi. 10.1007/s00330-023-10342-7
- By:
- Publication type:
- Article
Consensus report from the 10th Global Forum for Liver Magnetic Resonance Imaging: developments in HCC management.
- Published in:
- European Radiology, 2023, v. 33, n. 12, p. 9152, doi. 10.1007/s00330-023-09928-y
- By:
- Publication type:
- Article
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussion.
- Published in:
- European Radiology, 2023, v. 33, n. 12, p. 9167, doi. 10.1007/s00330-023-09919-z
- By:
- Publication type:
- Article
HELP PHARMACEUTICAL INDUSTRY TO BUILD MEANINGFUL PERSONALIZED HEALTHCARE PROFESSIONAL EXPERIENCE: THE APPLICATION OF THE BRAND LEADERSHIP CIRCLE TOOL TO OPTIMIZE AND INNOVATE ACROSS THE VALUE CHAIN AS PART OF A SUCCESSFUL BUSINESS MODEL.
- Published in:
- Health & Society, 2024, v. 4, n. 3, p. 180, doi. 10.51249/hs.v4i03.2104
- By:
- Publication type:
- Article
Natural immunity to SARS-CoV-2 and breakthrough infections in vaccinated and unvaccinated patients with cancer.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
- Published in:
- 2021
- By:
- Publication type:
- corrected article
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Clinical implications of heterogeneity in PD-L1 immunohistochemical detection in hepatocellular carcinoma: the Blueprint-HCC study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Integrated analysis of multiple receptor tyrosine kinases identifies Axl as a therapeutic target and mediator of resistance to sorafenib in hepatocellular carcinoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Blood Epstein-Barr virus DNA does not predict outcome in advanced HIV-associated Hodgkin lymphoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Programmed Cell Death Ligand Expression Drives Immune Tolerogenesis across the Diverse Subtypes of Neuroendocrine Tumours.
- Published in:
- Neuroendocrinology, 2021, v. 111, n. 5, p. 465, doi. 10.1159/000506745
- By:
- Publication type:
- Article
Systemic Inflammatory Response Is a Prognostic Marker in HIV-Infected Patients with Hepatocellular Carcinoma.
- Published in:
- Oncology, 2017, v. 93, n. 6, p. 395, doi. 10.1159/000479521
- By:
- Publication type:
- Article
Challenges and Opportunities in the Clinical Development of STING Agonists for Cancer Immunotherapy.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 10, p. 3323, doi. 10.3390/jcm9103323
- By:
- Publication type:
- Article
Comparative Efficacy of Atezolizumab plus Bevacizumab and Other Treatment Options for Patients with Unresectable Hepatocellular Carcinoma: A Network Meta-Analysis.
- Published in:
- Liver Cancer (2235-1795), 2021, v. 10, n. 3, p. 240, doi. 10.1159/000515302
- By:
- Publication type:
- Article
An Inflammation Based Score Can Optimize the Selection of Patients with Advanced Cancer Considered for Early Phase Clinical Trials.
- Published in:
- PLoS ONE, 2014, v. 9, n. 1, p. 1, doi. 10.1371/journal.pone.0083279
- By:
- Publication type:
- Article
A Pilot Randomized, Placebo Controlled, Double Blind Phase I Trial of the Novel SIRT1 Activator SRT2104 in Elderly Volunteers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 12, p. 1, doi. 10.1371/journal.pone.0051395
- By:
- Publication type:
- Article
Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers.
- Published in:
- PLoS ONE, 2012, v. 7, n. 11, p. 1, doi. 10.1371/journal.pone.0049814
- By:
- Publication type:
- Article
Geographic and temporal trends in aetiology, incidence and mortality from hepatocellular carcinoma in European Union 15+ countries.
- Published in:
- Liver Cancer International, 2023, v. 4, n. 3, p. 109, doi. 10.1002/lci2.77
- By:
- Publication type:
- Article
Development and validation of a therapy‐independent hepatocellular carcinoma survival prediction score.
- Published in:
- Liver Cancer International, 2022, v. 3, n. 2, p. 82, doi. 10.1002/lci2.45
- By:
- Publication type:
- Article
Mutations in circulating cell‐free tumour DNA: Predictors of survival in hepatocellular carcinoma.
- Published in:
- Liver Cancer International, 2021, v. 2, n. 2, p. 54, doi. 10.1002/lci2.34
- By:
- Publication type:
- Article
Regorafenib therapy for hepatocellular carcinoma in a HIV‐1‐infected patient: A case report.
- Published in:
- Liver Cancer International, 2020, v. 1, n. 2, p. 51, doi. 10.1002/lci2.15
- By:
- Publication type:
- Article
A pathway towards precision: Setting the agenda for Liver Cancer International.
- Published in:
- Liver Cancer International, 2020, v. 1, n. 1, p. 5, doi. 10.1002/lci2.7
- By:
- Publication type:
- Article
T‐cell mediated responses against alpha‐foetoprotein in hepatocellular carcinoma: Relationship with hepatitis C virus infection, tumour phenotype and patients' survival.
- Published in:
- Liver Cancer International, 2021, v. 2, n. 1, p. 7, doi. 10.1002/lci2.22
- By:
- Publication type:
- Article
Gender-related Distribution of the Interleukin-1β and Interleukin-1 Receptor Antagonist Gene Polymorphisms in Patients with End-stage Liver Disease.
- Published in:
- Inflammation, 2010, v. 33, n. 4, p. 251, doi. 10.1007/s10753-009-9179-2
- By:
- Publication type:
- Article
Immunotoxicity from checkpoint inhibitor therapy: clinical features and underlying mechanisms.
- Published in:
- Immunology, 2020, v. 159, n. 2, p. 167, doi. 10.1111/imm.13141
- By:
- Publication type:
- Article
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity.
- Published in:
- Journal of Translational Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12967-022-03755-3
- By:
- Publication type:
- Article
Effects of immune checkpoint inhibitor associated endocrinopathies on cancer survival.
- Published in:
- Frontiers in Endocrinology, 2024, p. 1, doi. 10.3389/fendo.2024.1369268
- By:
- Publication type:
- Article
PRIME-HCC: phase Ib study of neoadjuvant ipilimumab and nivolumab prior to liver resection for hepatocellular carcinoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Outcome of liver cancer patients with SARS‐CoV‐2 infection: An International, Multicentre, Cohort Study.
- Published in:
- Liver International, 2022, v. 42, n. 8, p. 1891, doi. 10.1111/liv.15320
- By:
- Publication type:
- Article
Qualification of tumour mutational burden by targeted next‐generation sequencing as a biomarker in hepatocellular carcinoma.
- Published in:
- Liver International, 2021, v. 41, n. 1, p. 192, doi. 10.1111/liv.14706
- By:
- Publication type:
- Article
Management of Hepatocellular Cancer in the time of SARS‐CoV‐2.
- Published in:
- Liver International, 2020, v. 40, n. 8, p. 1823, doi. 10.1111/liv.14517
- By:
- Publication type:
- Article
The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma.
- Published in:
- Liver International, 2019, v. 39, n. 11, p. 2008, doi. 10.1111/liv.14220
- By:
- Publication type:
- Article
Therapeutic hierarchy in hepatocellular carcinoma: A dispute of evidence versus practice.
- Published in:
- Liver International, 2019, v. 39, n. 9, p. 1622, doi. 10.1111/liv.14173
- By:
- Publication type:
- Article
The Kings Score refines prognostic prediction in hepatocellular carcinoma: a novel application.
- Published in:
- Liver International, 2015, v. 35, n. 11, p. 2458, doi. 10.1111/liv.12841
- By:
- Publication type:
- Article